Jacobs Levy Equity Management, Inc Cara Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $448,332 - $1.23 Million	-747,220 Reduced 51.74%	696,868 $515,000
Q3 2023 Nov 16, 2023	BUY	$1.67 - $3.33 $703,414 - $1.4 Million	421,206 Added 41.18%	1,444,088 $2.43 Million
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $2.89 Million - $5.05 Million	1,022,882 New	1,022,882 $2.89 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $6.84 Million - $12.7 Million	-918,256 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $71,826 - $91,408	-7,226 Reduced 0.78%	918,256 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $414,122 - $626,537	34,539 Added 3.88%	925,482 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $6.25 Million - $8.69 Million	541,275 Added 154.8%	890,943 $13.8 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $3.21 Million - $7.58 Million	-259,627 Reduced 42.61%	349,668 $4.99 Million
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $1.46 Million - $2.1 Million	96,799 Added 18.89%	609,295 $13.2 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $1.62 Million - $2.06 Million	127,745 Added 33.2%	512,496 $7.75 Million
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $4.13 Million - $5.99 Million	334,448 Added 664.87%	384,751 $4.9 Million
Q2 2020 Aug 17, 2020	BUY	$12.39 - $17.33 $623,254 - $871,750	50,303 New	50,303 $860,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.